Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7403
Rank
$0.56 B
Marketcap
$16.12
Share price
2.98%
Change (1 day)
-48.69%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Cash on Hand

Cash on Hand as of March 2026 : $5.01 Million USD

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company has $5.01 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avalon Pharma (Middle East Pharmaceutical) - Cash on Hand chart (from 2023 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$9.17 M51.94%
2024-12-31$6.03 M49.64%
2023-12-31$4.03 M